Characterizing clinical heterogeneity by whole-genome sequencing of 591 patients with Hemoglobin H disease
Variant / mechanism
Genetic modifiers: α-globin cluster variants and the HBS1L-MYB (HMIP) locus associated with Hb Bart's levels
Summary
This whole-genome study, the largest to date in Hemoglobin H disease, includes 591 well-characterized patients and 1,246 ancestry-matched controls from Southern China. Case-control analysis identified two independent variants at the α-globin cluster (rs199594877 and rs34583256), more frequent in patients, with rs199594877 enriched in carriers of Hb Constant Spring. Case-only analysis of 50 quantitative clinical traits identified six loci associated with hematological and iron metabolism phenotypes. At the HBS1L-MYB (HMIP) locus, rs11759553 was associated with increased Hb Bart's (γ4) levels (P = 3.66 × 10⁻¹⁴), in contrast, according to the authors, with the beneficial effect of this locus in β-hemoglobinopathies.
Synthesis written by Geno'X. For the full original abstract, please refer to the source publication.
Analysis
A genome-phenome resource that helps explain why two patients with the same α-globin genotype differ in severity, but with no immediate consequence for counselling or management. The abstract mentions no replication cohort, and the opposite effect of the HMIP locus compared with β-hemoglobinopathies needs functional validation before any prognostic use.
Analysis by Dr Thibaut Benquey
Why this score?
Clinical impact: 1/3 · Evidence strength: 2/3 · Novelty: 1/2 · Sample size: 1/1 · Publication status: 1/1 → Total: 6/10
Keywords
Every Wednesday · Annotated selection · Free · Unsubscribe anytime